Revolution Medicines, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-108.4M | $69.6M |
| FY2019 | — | $-152.6M | $16.7M |
| FY2020 | — | $474.7M | $104.3M |
| FY2021 | — | $602.6M | $108.5M |
| FY2022 | — | $685.2M | $161.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-108.4M | $69.6M |
| FY2019 | — | $-152.6M | $16.7M |
| FY2020 | — | $474.7M | $104.3M |
| FY2021 | — | $602.6M | $108.5M |
| FY2022 | — | $685.2M | $161.4M |